Upstream Bio Financials
| UPB Stock | 8.75 4.05 31.64% |
Upstream Bio Balance Sheet Chart
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 42.17 | 40.16 |
|
|
The essential information of the day-to-day investment outlook for Upstream Bio includes many different criteria found on its balance sheet. An individual investor should research Upstream Bio's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Upstream Bio.
Net Income |
|
Upstream | Select Account or Indicator | Build AI portfolio with Upstream Stock |
Please note, the presentation of Upstream Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Upstream Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Upstream Bio's management manipulating its earnings.
Upstream Bio Stock Summary
Upstream Bio competes with Zenas BioPharma, Intellia Therapeutics, Wave Life, Relay Therapeutics, and Pharvaris. Upstream Bio is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US91678A1079 |
| Business Address | 890 Winter Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | upstreambio.com |
| Phone | 781 208 2466 |
Upstream Bio Key Financial Ratios
| Return On Equity | -0.41 | ||||
| Operating Margin | (55.39) % | ||||
| Price To Sales | 168.93 X | ||||
| Revenue | 2.37 M | ||||
| Gross Profit | 2.8 M |
Upstream Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Upstream Bio's current stock value. Our valuation model uses many indicators to compare Upstream Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Upstream Bio competition to find correlations between indicators driving Upstream Bio's intrinsic value. More Info.Upstream Bio is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At present, Upstream Bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Upstream Bio's earnings, one of the primary drivers of an investment's value.Most indicators from Upstream Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Upstream Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.The current year's Issuance Of Capital Stock is expected to grow to about 510.3 M, whereas Selling General Administrative is forecasted to decline to about 12.6 M.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Income | 4.2M | 12.1M | 13.9M | 14.6M | Net Interest Income | 4.2M | 12.1M | 13.9M | 14.6M |
Upstream Bio fundamental ratios Correlations
Click cells to compare fundamentals
Upstream Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Today, most investors in Upstream Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Upstream Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Upstream Bio growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Upstream Bio February 15, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Upstream Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Upstream Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Upstream Bio based on widely used predictive technical indicators. In general, we focus on analyzing Upstream Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Upstream Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 57.85 | |||
| Value At Risk | (12.87) | |||
| Potential Upside | 7.84 |
Complementary Tools for Upstream Stock analysis
When running Upstream Bio's price analysis, check to measure Upstream Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio is operating at the current time. Most of Upstream Bio's value examination focuses on studying past and present price action to predict the probability of Upstream Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio's price. Additionally, you may evaluate how the addition of Upstream Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |